Ecopharmacovigilance is a crucial aspect of pharmacology that delves into the environmental impact of pharmaceutical substances, specifically focusing on their pharmacodynamics. Pharmacodynamics involves the study of how drugs interact with the body and the subsequent biological responses. In the context of ecopharmacovigilance, it extends beyond human health to assess the effects of pharmaceuticals on ecosystems and wildlife. Understanding the pharmacodynamics of drugs in the environment is vital for evaluating potential ecological risks. It encompasses the examination of how drugs persist, transform, and exert their effects in various environmental compartments. This field explores the intricate interplay between pharmaceuticals and non-target organisms, assessing both short-term and long-term impacts on biodiversity and ecosystem functioning. By scrutinizing pharmacodynamic aspects, ecopharmacovigilance aims to identify potential hazards posed by pharmaceutical residues in the environment and develop strategies to mitigate adverse effects. This involves comprehensive research to comprehend the fate of drugs in environmental matrices, their bioaccumulation, and potential consequences for ecosystems. Ultimately, integrating pharmacodynamics into ecopharmacovigilance practices ensures a holistic approach to pharmaceutical safety, addressing concerns beyond human health to safeguard the delicate balance of our ecosystems.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand